• Thursday, April 14, 2016
    Groundbreaking for Lonza Houston, Inc.’s State-of-the-Art Biotech Facility in Pearland

    For Immediate Release
    April 14, 2016

    Matt Buchanan
    Pearland Economic Development Corporation

    Groundbreaking for Lonza Houston, Inc.’s State-of-the-Art Biotech Facility in Pearland
    Leading supplier for pharmaceutical and biotech industries breaks ground on large facility in Pearland’s Lower Kirby District

    PEARLAND, Texas — Lonza Houston, Inc. (Lonza), along with leadership from the City of Pearland and the Pearland Economic Development Corporation (PEDC), kicked off construction on March 29th with a groundbreaking ceremony for Lonza’s new biotech facility for viral and immunotherapy development and manufacturing in Pearland’s Lower Kirby District.

    Lonza is a global leader in the field of viral and cell therapy manufacturing, creating products that support safer and healthier living.  As a leading supplier for the pharmaceutical, biotech and special ingredient markets, Lonza’s products and services range from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers. 

    “The City of Pearland is excited to welcome Lonza as the latest medical and life science employer to choose to locate in Pearland,” said Pearland Mayor Tom Reid. “It has been a long-standing goal of the City to cultivate a broad spectrum of medical and life science-related organizations in our community.  Following on the heels of Cardiovascular Systems, Inc., Merit Medical Systems, Base Pair Biotechnologies, and Kelsey-Seybold, Lonza’s interest in Pearland is a testament to our efforts and willingness to work with businesses interested in investing in our city.”

    The state-of-the-art facility will house office space, process development, and quality control laboratories and a fully segregated fill/finish suite, allowing Lonza to more than double its current capacity for the production of viral gene and virally modified therapeutics. The planned facility will also contain independent modular cleanrooms for up to 2,000 L-scale production in single-use bioreactors, along with cleanrooms designed to meet the requirements for the manufacture of cell therapy products for use in the U.S. and European markets.

    The facility, which is being designed and constructed in collaboration with Pinchal & Co., Creed Commercial Development, ARCO Design/Build, and CRB, will be located on an 11-acre site on Kirby Drive and will initially be home to over 80 employees with expected growth beyond that to include administrative, manufacturing, process development and quality assurance personnel.

    “Lonza is committed to growing our cell and gene therapy capabilities in Pearland. The curative potential of gene therapy continues to grow, and Lonza is on the forefront of working with clients to help them treat diseases such as cancer and cardiovascular diseases. Our team works with innovative designs and with novel cutting-edge technologies, so we are building in an area that is serving as a growing hub for the healthcare sector,” said Stefan Troger, Senior Vice President of Operations, Emerging Technologies Business Unit for Lonza’s Pharma&Biotech segment.

    “As a Pearland resident since 2000, it is an honor to be contributing to the growth of the city,” said Ricardo Jimenez, Site Director, Lonza Houston Inc. “Pearland has shown great support of the life science sector, and the Lower Kirby District is a perfect example of that. It has been a great journey of growth for the dedicated team at Lonza Houston, and I look forward to continued growth.”

    The Lower Kirby District consists of 1,200 acres located on the western border of Pearland facing South Beltway 8.  It is well positioned to capture a significant portion of office, retail, commercial and industrial projects as the Houston market continues to grow and expand. Existing developments within the Lower Kirby District include Merit Medical’s R&D and manufacturing facility, Dover Energy’s regional manufacturing and operations center, Mitsubishi Heavy Industries Compressor Corp.’s office and manufacturing facility, Cardiovascular Systems, Inc.’s medical device manufacturing facility, Pearland Surgery Center and Bass Pro Shop.


    About PEDC
    Established in 1995, the Pearland Economic Development Corporation promotes, assists and enhances the economic development activities and quality of life within Pearland, Texas. In bringing new and existing businesses to the area, the organization attracts capital investment to add to the city’s tax base and helps to increase the number of employment opportunities for residents. For more information, visit www.pearlandedc.com.

    About Lonza
    Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.

    Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin 3B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.

    Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 9,800 full-time employees worldwide. The company generated sales of CHF 3.8 billion in 2015 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com.

    Lonza Contact Information
    Lonza Group Ltd
    Head Investor Relations 
    Dirk Oehlers 
    Tel +41 61 316 8540 
    Fax +41 61 316 9540 

    Lonza Group Ltd 
    Head Corporate Communications 
    Dominik Werner 
    Tel +41 61 316 8798 
    Fax +41 61 316 9540

    Lonza Group Ltd
    Head External Communications
    Constance Ward
    Tel +41 61 316 8840 
    Fax +41 61 316 9840

  • Find us on google maps